174 related articles for article (PubMed ID: 22747598)
1. Structure-based design of potent Bcl-2/Bcl-xL inhibitors with strong in vivo antitumor activity.
Zhou H; Aguilar A; Chen J; Bai L; Liu L; Meagher JL; Yang CY; McEachern D; Cong X; Stuckey JA; Wang S
J Med Chem; 2012 Jul; 55(13):6149-61. PubMed ID: 22747598
[TBL] [Abstract][Full Text] [Related]
2. Design of Bcl-2 and Bcl-xL inhibitors with subnanomolar binding affinities based upon a new scaffold.
Zhou H; Chen J; Meagher JL; Yang CY; Aguilar A; Liu L; Bai L; Cong X; Cai Q; Fang X; Stuckey JA; Wang S
J Med Chem; 2012 May; 55(10):4664-82. PubMed ID: 22448988
[TBL] [Abstract][Full Text] [Related]
3. Structure-based discovery of BM-957 as a potent small-molecule inhibitor of Bcl-2 and Bcl-xL capable of achieving complete tumor regression.
Chen J; Zhou H; Aguilar A; Liu L; Bai L; McEachern D; Yang CY; Meagher JL; Stuckey JA; Wang S
J Med Chem; 2012 Oct; 55(19):8502-14. PubMed ID: 23030453
[TBL] [Abstract][Full Text] [Related]
4. Studies leading to potent, dual inhibitors of Bcl-2 and Bcl-xL.
Bruncko M; Oost TK; Belli BA; Ding H; Joseph MK; Kunzer A; Martineau D; McClellan WJ; Mitten M; Ng SC; Nimmer PM; Oltersdorf T; Park CM; Petros AM; Shoemaker AR; Song X; Wang X; Wendt MD; Zhang H; Fesik SW; Rosenberg SH; Elmore SW
J Med Chem; 2007 Feb; 50(4):641-62. PubMed ID: 17256834
[TBL] [Abstract][Full Text] [Related]
5. BM-1197: a novel and specific Bcl-2/Bcl-xL inhibitor inducing complete and long-lasting tumor regression in vivo.
Bai L; Chen J; McEachern D; Liu L; Zhou H; Aguilar A; Wang S
PLoS One; 2014; 9(6):e99404. PubMed ID: 24901320
[TBL] [Abstract][Full Text] [Related]
6. Pyrazole and pyrimidine phenylacylsulfonamides as dual Bcl-2/Bcl-xL antagonists.
Schroeder GM; Wei D; Banfi P; Cai ZW; Lippy J; Menichincheri M; Modugno M; Naglich J; Penhallow B; Perez HL; Sack J; Schmidt RJ; Tebben A; Yan C; Zhang L; Galvani A; Lombardo LJ; Borzilleri RM
Bioorg Med Chem Lett; 2012 Jun; 22(12):3951-6. PubMed ID: 22608393
[TBL] [Abstract][Full Text] [Related]
7. Development of 3-phenyl-N-(2-(3-phenylureido)ethyl)-thiophene-2-sulfonamide compounds as inhibitors of antiapoptotic Bcl-2 family proteins.
Yang C; Chen S; Zhou M; Li Y; Li Y; Zhang Z; Liu Z; Ba Q; Li J; Wang H; Yan X; Ma D; Wang R
ChemMedChem; 2014 Jul; 9(7):1436-52. PubMed ID: 24782462
[TBL] [Abstract][Full Text] [Related]
8. Discovery of PROTAC BCL-X
Zhang X; Thummuri D; Liu X; Hu W; Zhang P; Khan S; Yuan Y; Zhou D; Zheng G
Eur J Med Chem; 2020 Apr; 192():112186. PubMed ID: 32145645
[TBL] [Abstract][Full Text] [Related]
9. Discovery of potent Mcl-1/Bcl-xL dual inhibitors by using a hybridization strategy based on structural analysis of target proteins.
Tanaka Y; Aikawa K; Nishida G; Homma M; Sogabe S; Igaki S; Hayano Y; Sameshima T; Miyahisa I; Kawamoto T; Tawada M; Imai Y; Inazuka M; Cho N; Imaeda Y; Ishikawa T
J Med Chem; 2013 Dec; 56(23):9635-45. PubMed ID: 24215352
[TBL] [Abstract][Full Text] [Related]
10. Structure-Guided Development of Potent Benzoylurea Inhibitors of BCL-X
Roy MJ; Vom A; Okamoto T; Smith BJ; Birkinshaw RW; Yang H; Abdo H; White CA; Segal D; Huang DCS; Baell JB; Colman PM; Czabotar PE; Lessene G
J Med Chem; 2021 May; 64(9):5447-5469. PubMed ID: 33904752
[TBL] [Abstract][Full Text] [Related]
11. Towards the next generation of dual Bcl-2/Bcl-xL inhibitors.
Varnes JG; Gero T; Huang S; Diebold RB; Ogoe C; Grover PT; Su M; Mukherjee P; Saeh JC; MacIntyre T; Repik G; Dillman K; Byth K; Russell DJ; Ioannidis S
Bioorg Med Chem Lett; 2014 Jul; 24(14):3026-33. PubMed ID: 24881567
[TBL] [Abstract][Full Text] [Related]
12. [Progress in small-molecule inhibitors of Bcl-2 family proteins].
Tang Y; Zhang DY; Wu XM
Yao Xue Xue Bao; 2008 Jul; 43(7):669-77. PubMed ID: 18819468
[TBL] [Abstract][Full Text] [Related]
13. Selective inhibitors of Bcl-2 and Bcl-xL: Balancing antitumor activity with on-target toxicity.
Hennessy EJ
Bioorg Med Chem Lett; 2016 May; 26(9):2105-14. PubMed ID: 26988306
[TBL] [Abstract][Full Text] [Related]
14. Pyrogallol-based molecules as potent inhibitors of the antiapoptotic Bcl-2 proteins.
Tang G; Yang CY; Nikolovska-Coleska Z; Guo J; Qiu S; Wang R; Gao W; Wang G; Stuckey J; Krajewski K; Jiang S; Roller PP; Wang S
J Med Chem; 2007 Apr; 50(8):1723-6. PubMed ID: 17378545
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis, and activity evaluation of broad-spectrum small-molecule inhibitors of anti-apoptotic Bcl-2 family proteins: characteristics of broad-spectrum protein binding and its effects on anti-tumor activity.
Zheng CH; Yang H; Zhang M; Lu SH; Shi D; Wang J; Chen XH; Ren XH; Liu J; Lv JG; Zhu J; Zhou YJ
Bioorg Med Chem Lett; 2012 Jan; 22(1):39-44. PubMed ID: 22172701
[TBL] [Abstract][Full Text] [Related]
16. Novel small-molecule inhibitors of Bcl-XL to treat lung cancer.
Park D; Magis AT; Li R; Owonikoko TK; Sica GL; Sun SY; Ramalingam SS; Khuri FR; Curran WJ; Deng X
Cancer Res; 2013 Sep; 73(17):5485-96. PubMed ID: 23824742
[TBL] [Abstract][Full Text] [Related]
17. DT2216-a Bcl-xL-specific degrader is highly active against Bcl-xL-dependent T cell lymphomas.
He Y; Koch R; Budamagunta V; Zhang P; Zhang X; Khan S; Thummuri D; Ortiz YT; Zhang X; Lv D; Wiegand JS; Li W; Palmer AC; Zheng G; Weinstock DM; Zhou D
J Hematol Oncol; 2020 Jul; 13(1):95. PubMed ID: 32677976
[TBL] [Abstract][Full Text] [Related]
18. A potent and highly efficacious Bcl-2/Bcl-xL inhibitor.
Aguilar A; Zhou H; Chen J; Liu L; Bai L; McEachern D; Yang CY; Meagher J; Stuckey J; Wang S
J Med Chem; 2013 Apr; 56(7):3048-3067. PubMed ID: 23448298
[TBL] [Abstract][Full Text] [Related]
19. Discovery and structure-activity relationship of antagonists of B-cell lymphoma 2 family proteins with chemopotentiation activity in vitro and in vivo.
Wendt MD; Shen W; Kunzer A; McClellan WJ; Bruncko M; Oost TK; Ding H; Joseph MK; Zhang H; Nimmer PM; Ng SC; Shoemaker AR; Petros AM; Oleksijew A; Marsh K; Bauch J; Oltersdorf T; Belli BA; Martineau D; Fesik SW; Rosenberg SH; Elmore SW
J Med Chem; 2006 Feb; 49(3):1165-81. PubMed ID: 16451081
[TBL] [Abstract][Full Text] [Related]
20. Discovery of potent and selective Bcl-2 inhibitors with acyl sulfonamide skeleton.
Wang B; Feng W; Wang J; Dong Y; Liu Y; Yao Y; Zhang J; Shi W; Liu L; Zhang H; He X; Chang X; Wang X; Xu H; Liu F; Feng J
Bioorg Med Chem; 2021 Oct; 47():116350. PubMed ID: 34536651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
